130 related articles for article (PubMed ID: 27427917)
1. Aggressive skin cancers in patients who experienced chronic GvHD after allogeneic bone marrow transplantation.
Zampaolo AS; Kanold J; Tournilhac O; Franck F; Bachelerie M; D'Incan M
Bone Marrow Transplant; 2017 Jan; 52(1):130-131. PubMed ID: 27427917
[No Abstract] [Full Text] [Related]
2. [Cutaneous manifestations of graft versus host disease in a population of pediatric and young adults patients].
Martino C; Calvano R; Boggio P; Scacchi MF; Sojo M; Carbajosa A; Makiya M; Giachetti A
Arch Argent Pediatr; 2020 Oct; 118(5):e468-e475. PubMed ID: 32924403
[TBL] [Abstract][Full Text] [Related]
3. Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Matsuo Y; Kamezaki K; Takeishi S; Takenaka K; Eto T; Nonami A; Miyamoto T; Iwasaki H; Harada N; Nagafuji K; Teshima T; Akashi K
Intern Med; 2009; 48(16):1453-6. PubMed ID: 19687597
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
5. Naevi in allogeneic bone marrow transplantation recipients: the effect of graft-versus-host disease on naevi.
Andreani V; Richard MA; Blaise D; Gouvernet J; Grob JJ
Br J Dermatol; 2002 Sep; 147(3):433-41. PubMed ID: 12207581
[TBL] [Abstract][Full Text] [Related]
6. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Urban CH; Deutschmann A; Kerbl R; Lackner H; Schwinger W; Königsrainer A; Margreiter R
Bone Marrow Transplant; 2002 Oct; 30(8):535-7. PubMed ID: 12379895
[TBL] [Abstract][Full Text] [Related]
7. Acute graft-versus-host disease of the kidney in allogeneic rat bone marrow transplantation.
Higo S; Shimizu A; Masuda Y; Nagasaka S; Kajimoto Y; Kanzaki G; Fukui M; Nagahama K; Mii A; Kaneko T; Tsuruoka S
PLoS One; 2014; 9(12):e115399. PubMed ID: 25541735
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid syndrome complicating chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Sõhngen D; Heyll A; Meckenstock G; Aul C; Wolf HH; Schneider W; Specker C; Withold W
Am J Hematol; 1994 Oct; 47(2):143-4. PubMed ID: 8092133
[No Abstract] [Full Text] [Related]
9. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
[TBL] [Abstract][Full Text] [Related]
10. Guillain-Barre syndrome--pathological connection with GvHD after allogeneic bone marrow transplantation.
Nasilowska-Adamska B; Lysiak Z; Halaburda K; Szczepinski A; Ejduk A; Marianska B
Ann Transplant; 2006; 11(3):10-1. PubMed ID: 17494293
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations.
Grau JM; Casademont J; Monforte R; Marín P; Grañena A; Rozman C; Urbano-Márquez A
Bone Marrow Transplant; 1990 Jun; 5(6):435-7. PubMed ID: 2369684
[TBL] [Abstract][Full Text] [Related]
12. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
[TBL] [Abstract][Full Text] [Related]
13. Ocular complications of bone marrow transplantation.
Livesey SJ; Holmes JA; Whittaker JA
Eye (Lond); 1989; 3 ( Pt 3)():271-6. PubMed ID: 2693135
[TBL] [Abstract][Full Text] [Related]
14. Tretinoin for the treatment of cutaneous graft-versus-host disease.
Gryn J; Crilley P
Bone Marrow Transplant; 1990 Apr; 5(4):279-80. PubMed ID: 2104506
[TBL] [Abstract][Full Text] [Related]
15. Chronic Ulcer by Cutaneous GvHD After Bone Marrow Transplantation Treated With Skin Allograft From HLA-Identical Donor: Case Report and Literature Review.
Amendola F; Gazzola R; Lombardo M; Caminiti R; Dagna L; Baruffaldi-Preis FW
Int J Low Extrem Wounds; 2016 Jun; 15(2):139-41. PubMed ID: 27009789
[TBL] [Abstract][Full Text] [Related]
16. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
[TBL] [Abstract][Full Text] [Related]
17. Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
Ancín I; Ferrá C; Gallardo D; Peris J; Berlanga J; Gonzalez JR; Virgili N; Grañena A
Bone Marrow Transplant; 2001 Jul; 28(1):39-45. PubMed ID: 11498742
[TBL] [Abstract][Full Text] [Related]
18. Graft-Versus-Host Disease Presenting as a Myositis and Myonecrosis.
Patel DM; Newallo DS; Barron B
Clin Nucl Med; 2020 Nov; 45(11):e495-e497. PubMed ID: 32701802
[TBL] [Abstract][Full Text] [Related]
19. Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients.
Min CK; Eom KS; Lee S; Kim DW; Lee JW; Min WS; Kim CC
Bone Marrow Transplant; 2001 May; 27(9):999-1005. PubMed ID: 11436112
[TBL] [Abstract][Full Text] [Related]
20. Evolving strategies to address adverse transplant outcomes associated with T cell depletion.
Drobyski WR
J Hematother Stem Cell Res; 2000 Jun; 9(3):327-37. PubMed ID: 10894354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
